139 related articles for article (PubMed ID: 31704958)
1. Structural insights into mutagenicity of anticancer nucleoside analog cytarabine during replication by DNA polymerase η.
Rechkoblit O; Johnson RE; Buku A; Prakash L; Prakash S; Aggarwal AK
Sci Rep; 2019 Nov; 9(1):16400. PubMed ID: 31704958
[TBL] [Abstract][Full Text] [Related]
2. Structural basis for polymerase η-promoted resistance to the anticancer nucleoside analog cytarabine.
Rechkoblit O; Choudhury JR; Buku A; Prakash L; Prakash S; Aggarwal AK
Sci Rep; 2018 Aug; 8(1):12702. PubMed ID: 30140014
[TBL] [Abstract][Full Text] [Related]
3. Translesion synthesis DNA polymerases η, ι, and ν promote mutagenic replication through the anticancer nucleoside cytarabine.
Yoon JH; Roy Choudhury J; Prakash L; Prakash S
J Biol Chem; 2019 Dec; 294(50):19048-19054. PubMed ID: 31685662
[TBL] [Abstract][Full Text] [Related]
4. Interaction between DNA Polymerase lambda and anticancer nucleoside analogs.
Garcia-Diaz M; Murray MS; Kunkel TA; Chou KM
J Biol Chem; 2010 May; 285(22):16874-9. PubMed ID: 20348107
[TBL] [Abstract][Full Text] [Related]
5. The dominant role of proofreading exonuclease activity of replicative polymerase ε in cellular tolerance to cytarabine (Ara-C).
Tsuda M; Terada K; Ooka M; Kobayashi K; Sasanuma H; Fujisawa R; Tsurimoto T; Yamamoto J; Iwai S; Kadoda K; Akagawa R; Huang SN; Pommier Y; Sale JE; Takeda S; Hirota K
Oncotarget; 2017 May; 8(20):33457-33474. PubMed ID: 28380422
[TBL] [Abstract][Full Text] [Related]
6. Modulation of intracellular metabolism of cytosine arabinoside in acute myeloid leukemia by granulocyte-macrophage colony-stimulating factor.
Reuter C; Auf der Landwehr U; Schleyer E; Zühlsdorf M; Ameling C; Rolf C; Wörmann B; Büchner T; Hiddemann W
Leukemia; 1994 Feb; 8(2):217-25. PubMed ID: 8309245
[TBL] [Abstract][Full Text] [Related]
7. Kinetic investigation of the polymerase and exonuclease activities of human DNA polymerase ε holoenzyme.
Zahurancik WJ; Suo Z
J Biol Chem; 2020 Dec; 295(50):17251-17264. PubMed ID: 33051204
[TBL] [Abstract][Full Text] [Related]
8. Mismatch-induced conformational distortions in polymerase beta support an induced-fit mechanism for fidelity.
Arora K; Beard WA; Wilson SH; Schlick T
Biochemistry; 2005 Oct; 44(40):13328-41. PubMed ID: 16201758
[TBL] [Abstract][Full Text] [Related]
9. Molecular structure of a DNA decamber containing an anticancer nucleoside arabinosylcytosine: conformational perturbation by arabinosylcytosine in B-DNA.
Gao YG; van der Marel GA; van Boom JH; Wang AH
Biochemistry; 1991 Oct; 30(41):9922-31. PubMed ID: 1911784
[TBL] [Abstract][Full Text] [Related]
10. Extending the understanding of mutagenicity: structural insights into primer-extension past a benzo[a]pyrene diol epoxide-DNA adduct.
Perlow RA; Broyde S
J Mol Biol; 2003 Apr; 327(4):797-818. PubMed ID: 12654264
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous incorporations of two anticancer drugs into DNA. The structures of formaldehyde-cross-linked adducts of daunorubicin-d(CG(araC)GCG) and doxorubicin-d(CA(araC)GTG) complexes at high resolution.
Zhang H; Gao YG; van der Marel GA; van Boom JH; Wang AH
J Biol Chem; 1993 May; 268(14):10095-101. PubMed ID: 8486678
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of arabinocytosine (AraC) toxicity to AML cells by a differentiation agent combination.
Wang X; Harrison JS; Studzinski GP
J Steroid Biochem Mol Biol; 2016 Nov; 164():72-78. PubMed ID: 26319201
[TBL] [Abstract][Full Text] [Related]
13. Effect of cytarabine on the NMR structure of a model okazaki fragment from the SV40 genome.
Gmeiner WH; Konerding D; James TL
Biochemistry; 1999 Jan; 38(4):1166-75. PubMed ID: 9930976
[TBL] [Abstract][Full Text] [Related]
14. Imbalanced DNA synthesis induced by cytosine arabinoside and fludarabine in human leukemia cells.
Carbone GM; Catapano CV; Fernandes DJ
Biochem Pharmacol; 2001 Jul; 62(1):101-10. PubMed ID: 11377401
[TBL] [Abstract][Full Text] [Related]
15. Functional consequences of the arabinosylcytosine structural lesion in DNA.
Mikita T; Beardsley GP
Biochemistry; 1988 Jun; 27(13):4698-705. PubMed ID: 2458756
[TBL] [Abstract][Full Text] [Related]
16. Conformational perturbation of the anticancer nucleotide arabinosylcytosine on Z-DNA: molecular structure of (araC-dG)3 at 1.3 A resolution.
Zhang H; van der Marel GA; van Boom JH; Wang AH
Biopolymers; 1992 Nov; 32(11):1559-69. PubMed ID: 1457732
[TBL] [Abstract][Full Text] [Related]
17. Molecular Insights into the Translesion Synthesis of Benzyl-Guanine from Molecular Dynamics Simulations: Structural Evidence of Mutagenic and Nonmutagenic Replication.
Wilson KA; Wetmore SD
Biochemistry; 2017 Apr; 56(13):1841-1853. PubMed ID: 28290677
[TBL] [Abstract][Full Text] [Related]
18. Evidence for a Watson-Crick hydrogen bonding requirement in DNA synthesis by human DNA polymerase kappa.
Wolfle WT; Washington MT; Kool ET; Spratt TE; Helquist SA; Prakash L; Prakash S
Mol Cell Biol; 2005 Aug; 25(16):7137-43. PubMed ID: 16055723
[TBL] [Abstract][Full Text] [Related]
19. Effects of the O2' hydroxyl group on Z-DNA conformation: structure of Z-RNA and (araC)-[Z-DNA].
Teng MK; Liaw YC; van der Marel GA; van Boom JH; Wang AH
Biochemistry; 1989 Jun; 28(12):4923-8. PubMed ID: 2475172
[TBL] [Abstract][Full Text] [Related]
20. TDP1 is Critical for the Repair of DNA Breaks Induced by Sapacitabine, a Nucleoside also Targeting ATM- and BRCA-Deficient Tumors.
Al Abo M; Sasanuma H; Liu X; Rajapakse VN; Huang SY; Kiselev E; Takeda S; Plunkett W; Pommier Y
Mol Cancer Ther; 2017 Nov; 16(11):2543-2551. PubMed ID: 28802254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
